Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)

Q: What does CUSIP 21833P301 represent in this 13F holders report?

CUSIP 21833P301 is the security identifier for CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

Q: How many institutions held CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value in Q2 2023?

28 institutional investors reported CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 21833P301

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 17,685,185
Total 13F shares: 739,439
Share change: +16,104
Total reported value: $5,797,676
Price per share: $7.84
Number of holders: 28
Value change: +$132,453
Number of buys: 6
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 21833P301?
CUSIP 21833P301 identifies CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 21833P301:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Rachael Louise Brake	3/4/5	Chief Scientific Officer	— class O/S missing	1,400,000	$6,958,000	—	13 Feb 2023	3/4/5
Craig Stuart Millian	3/4/5	Chief Operating Officer	— class O/S missing	934,645	$4,645,186	—	13 Feb 2023	3/4/5
Ikarian Capital, LLC	13F	Company	1.1%	192,260	$1,397,730	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	1%	179,455	$1,304,642	—	31 Mar 2023	13F
Sio Capital Management, LLC	13F	Company	0.85%	150,000	$1,090,500	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.41%	72,157	$524,581	—	31 Mar 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.21%	37,976	$276,086	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.19%	32,865	$238,928	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.08%	13,681	$99,461	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.07%	13,179	$95,811	—	31 Mar 2023	13F
Virtu Financial LLC	13F	Company	0.06%	10,077	$73,000	—	31 Mar 2023	13F
Tekla Capital Management LLC	13F	Company	0.03%	5,143	$37,390	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.03%	4,844	$35,216	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.02%	3,615	$26,282	—	31 Mar 2023	13F
FMR LLC	13F	Company	0.02%	3,365	$24,463	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	2,265	$16,467	—	31 Mar 2023	13F
JTC Employer Solutions Trustee Ltd	13F	Company	0.01%	1,106	$8,000	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	491	$4,000	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	336	$2,442	—	31 Mar 2023	13F
Cutler Group LLC / CA	13F	Company	0%	353	$2,000	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0%	189	$1,000	—	31 Mar 2023	13F
Carmichael Hill & Associates, Inc.	13F	Company	0%	100	$727	—	31 Mar 2023	13F
IFP Advisors, Inc	13F	Company	— mixed-class rows	103 mixed-class rows	$605	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	79	$575	—	31 Mar 2023	13F
Accel Wealth Management	13F	Company	0%	46	$334	—	31 Mar 2023	13F
HighMark Wealth Management LLC	13F	Company	0%	41	$298	—	31 Mar 2023	13F
Annapolis Financial Services, LLC	13F	Company	0%	23	$168	—	31 Mar 2023	13F
Belpointe Asset Management LLC	13F	Company	0%	22	$160	—	31 Mar 2023	13F
STUDIO INVESTMENT MANAGEMENT LLC	13F	Company	0%	9	$65	—	31 Mar 2023	13F
NewEdge Advisors, LLC	13F	Company	0%	8	$58	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1	$7	—	31 Mar 2023	13F
Sandy Spring Bank	13F	Company	0%	1	$7	—	31 Mar 2023	13F

Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) as of Q2 2023

As of 30 Jun 2023, Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 739,439 shares. The largest 10 holders included Ikarian Capital, LLC, VANGUARD GROUP INC, Sio Capital Management, LLC, BlackRock Inc., BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Tekla Capital Management LLC, and FMR LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.